With RU-486, will more physicians provide abortions?

Article Abstract:

Roussel-Uclaf SA, French manufacturer of RU-486, plans to request investigational new drug approval from the Food and Drug Administration (FDA) to test the drug in the US. There is speculation about whether the pro-abortion climate in the US is right for introducing the drug at this time. Some believe that more physicians would perform chemical abortions than are willing to do them surgically. It is also hoped that if the drug is approved, the FDA will set restrictions on its use, such as that it only be performed in specified clinics under strict supervision.

Ethical aspects, Abortifacients

---

Anesthesiologists question claims in abortion debate

Article Abstract:

An article in the St. Louis Post-Dispatch has triggered a debate over the possible deleterious effects of anesthesia on fetuses which may result in fetal death. Anesthesiologists dispute the claims of the St. Louis article and point out that fetuses seem fairly safe from the use of anesthesia. Anesthesiologist Dr. David Birnbach points out that even high dosages can be used safely. New legislation introduced into Congress by Reps. Charles T. Canady and Tom Coburn proposes a ban on late term abortions known as 'partial birth' abortions.

Pharmaceutical Preparation Manufacturing, Other Justice, Public Order, and Safety Activities, Anesthetic Preparations, Abortion & Civil Rights NEC, Political aspects, Anesthesia, Pregnancy, Civil rights, Fetal death, Anesthetics

---

Drug maker getting ready to bring RU-486 to U.S. market

Article Abstract:

The French pharmaceutical company Roussel-Uclaf SA hopes to market mifepristone, known as RU-486, the morning-after contraceptive, in the United States. The company expects Pres Bill Clinton's pro-abortion stance to soften opposition to sale of the drug. However, pro-life protesters may instigate boycotts of all the company's products plus the products of Hoechst Celanese Corp, in which Roussel-Uclaf owns a majority interest.

Contraceptives

Similar abstracts:

• Abstracts: Clinicians' self-assessment: questions and answers in substance abuse treatment
• Abstracts: Will all physicians someday be working for 'company'? Physicians should learn: quitters can't win
• Abstracts: Improving access by taking the clinic to the people. Taking a computerized tour through the human body. Doctors of invention: inspiration - and a lot of perspiration - help physician-inventors build a better device

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.